These results further align with multiple studies showing that transgenic mice co-expressing wild-type SOD1 and familial ALS SOD1 suffer from an accelerated disease progression (Fukada et al., 2001; Jaarsma et al., 2000). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.